Wed, August 16, 2023
Tue, August 15, 2023
Mon, August 14, 2023
Sun, August 13, 2023
Fri, August 11, 2023

Kevin Steinke Maintained (CCRN) at Buy with Decreased Target to $29 on, Aug 14th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-29-on-aug-14th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Kevin Steinke of Barrington Research, Maintained "Cross Country Healthcare, Inc." (CCRN) at Buy with Decreased Target from $35 to $29 on, Aug 14th, 2023.

Kevin has made no other calls on CCRN in the last 4 months.



There are 3 other peers that have a rating on CCRN. Out of the 3 peers that are also analyzing CCRN, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jonathan Yong of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Tuesday, August 8th, 2023
  • Tobey Sommer of "Truist Securities" Maintained at Hold with Decreased Target to $25 on, Tuesday, May 2nd, 2023


This is the rating of the analyst that currently disagrees with Kevin


  • Trevor Romeo of "William Blair" Initiated at Buy on, Monday, June 26th, 2023

Publication Contributing Sources